UPDATE 1-FDA rejects BioMarin's DMD drug
January 14, 2016 at 08:51 AM EST
Jan 14 (Reuters) - BioMarin Pharmaceutical Inc said on Thursday the U.S. Food and Drug Administration had rejected the company's drug to treat a rare muscle-wasting disorder.